Cargando…

Tasimelteon safely and effectively improves sleep in Smith–Magenis syndrome: a double-blind randomized trial followed by an open-label extension

PURPOSE: To assess the efficacy of tasimelteon to improve sleep in Smith–Magenis syndrome (SMS). METHODS: A 9-week, double-blind, randomized, two-period crossover study was conducted at four US clinical centers. Genetically confirmed patients with SMS, aged 3 to 39, with sleep complaints participate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polymeropoulos, Christos M., Brooks, Justin, Czeisler, Emily L., Fisher, Michaela A., Gibson, Mary M., Kite, Kailey, Smieszek, Sandra P., Xiao, Changfu, Elsea, Sarah H., Birznieks, Gunther, Polymeropoulos, Mihael H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629754/ https://www.ncbi.nlm.nih.gov/pubmed/34316024 http://dx.doi.org/10.1038/s41436-021-01282-y

Ejemplares similares

Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial
por: Polymeropoulos, Christos M., et al.
Publicado: (2022)

Simulated driving performance in healthy adults after night‐time administration of 20 mg tasimelteon
por: Torres, Rosarelis, et al.
Publicado: (2021)

Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study
por: Smieszek, Sandra P., et al.
Publicado: (2023)

Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Polymeropoulos, Christos M., et al.
Publicado: (2020)

Case report: A novel missense variant in melanopsin associates with delayed sleep phenotype: Whole genome sequencing study
por: Smieszek, Sandra P., et al.
Publicado: (2022)

Enrichment of Motilin Receptor Loss-of-Function Variants in Gastroparesis
por: Smieszek, Sandra P., et al.
Publicado: (2022)

Elevated plasma levels of CXCL16 in severe COVID-19 patients
por: Smieszek, Sandra P., et al.
Publicado: (2022)

Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study
por: Polymeropoulos, Vasilios M., et al.
Publicado: (2020)

Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility
por: Smieszek, Sandra P., et al.
Publicado: (2021)

Enrichment of Patients With Ehlers Danlos Syndrome in Idiopathic Gastroparesis—A Gene Set Enrichment Analysis
por: Smieszek, Sandra P., et al.
Publicado: (2022)

Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’
por: Smieszek, Sandra P., et al.
Publicado: (2021)

Corrigendum to “Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients” [Cytokine 148 (2021) 155662]
por: Smieszek, Sandra P., et al.
Publicado: (2022)

Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness
por: Czeisler, Mark É., et al.
Publicado: (2023)

Correlation of age-of-onset of Atopic Dermatitis with Filaggrin loss-of-function variant status
por: Smieszek, S. P., et al.
Publicado: (2020)

An observational study investigating the CRY1Δ11 variant associated with delayed sleep–wake patterns and circadian metabolic output
por: Smieszek, Sandra P., et al.
Publicado: (2021)

Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection
por: Kumar, Prabhakaran, et al.
Publicado: (2022)

Frameshift mutation hotspot identified in Smith-Magenis syndrome: case report and review of literature
por: Truong, Hoa T, et al.
Publicado: (2010)

Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment
por: Smieszek, Sandra P., et al.
Publicado: (2020)

Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake Disorder
por: Van Draanen, Lauren, et al.
Publicado: (2021)

Behavioral disturbance and treatment strategies in Smith-Magenis syndrome
por: Poisson, Alice, et al.
Publicado: (2015)

Acoustic Analysis of Phonation in Children With Smith–Magenis Syndrome
por: Hidalgo-De la Guía, Irene, et al.
Publicado: (2021)

Smith-magenis syndrome: A rare case report
por: Sinha, Rupam, et al.
Publicado: (2022)

RAI1 gene mutations: mechanisms of Smith–Magenis syndrome
por: Falco, Mariateresa, et al.
Publicado: (2017)

Cerebral Venous Thrombosis in a Patient With Smith-Magenis Syndrome
por: Zahoor, Hovra, et al.
Publicado: (2023)

Neurokinin‐1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial
por: Welsh, S.E., et al.
Publicado: (2021)

Possible underreporting of pathogenic variants in RAI1 causing Smith–Magenis syndrome
por: Boot, Erik, et al.
Publicado: (2021)

Surgical treatment of scoliosis in Smith-Magenis syndrome: a case report
por: Tsirikos, Athanasios I, et al.
Publicado: (2010)

Reversed gender ratio of autism spectrum disorder in Smith-Magenis syndrome
por: Nag, Heidi Elisabeth, et al.
Publicado: (2018)

Smith-Magenis Syndrome—Clinical Review, Biological Background and Related Disorders
por: Rinaldi, Berardo, et al.
Publicado: (2022)

Congenital Scoliosis in Smith–Magenis Syndrome: A Case Report and Review of the Literature
por: Li, Zheng, et al.
Publicado: (2015)

Hidradenitis Suppurativa in a Patient with Smith-Magenis Syndrome: A Case Report
por: McKenzie, Shanice A, et al.
Publicado: (2019)

Metabolic Profile of Patients with Smith-Magenis Syndrome: An Observational Study with Literature Review
por: Cipolla, Clelia, et al.
Publicado: (2023)

RAI1 Transcription Factor Activity Is Impaired in Mutants Associated with Smith-Magenis Syndrome
por: Carmona-Mora, Paulina, et al.
Publicado: (2012)

Parental experiences with behavioural problems in Smith–Magenis syndrome: The need for syndrome-specific competence
por: Nag, Heidi Elisabeth, et al.
Publicado: (2019)

Caregivers’ experience of sleep management in Smith–Magenis syndrome: a mixed-methods study
por: Agar, Georgie, et al.
Publicado: (2022)

Smith-Magenis Syndrome: Molecular Basis of a Genetic-Driven Melatonin Circadian Secretion Disorder
por: Poisson, Alice, et al.
Publicado: (2019)

SUN-691 Type 2 Diabetes Management in the Context of Smith-Magenis Syndrome: Case Report
por: Mulvaney, Kylie Tamm, et al.
Publicado: (2020)

Management of Attention Deficits and Behavioral Dyscontrol With an Evening-Dosed Methylphenidate Formulation in Smith-Magenis Syndrome
por: Narlesky, Matthew R, et al.
Publicado: (2022)

Loss of Rai1 enhances hippocampal excitability and epileptogenesis in mouse models of Smith–Magenis syndrome
por: Chang, Ya-Ting, et al.
Publicado: (2022)

First Case Report of Smith–Magenis Syndrome (SMS) Among the Arab Community in Nazareth: View and Overview
por: Nijim, Yousif, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9o40fhb342tn02vkhl50arptnc